Diagnostic and Clinical Impact of 18F-FDG PET/CT in Staging and Restaging Soft-Tissue Sarcomas of the Extremities and Trunk: Mono-Institutional Retrospective Study of a Sarcoma Referral Center.

Alessio AnnovazziSandra ReaCarmine ZoccaliRosa SciutoJacopo BaldiVincenzo AnelliMaria G PetrongariEdoardo PescarmonaRoberto BiaginiVirginia Ferraresi

Published in: Journal of clinical medicine (2020)

18F-FDG PET/CT altered therapy planning in 80 cases (16.4% for staging and 29.9% in restaging), both for disease upstaging (58.8%) and downstaging (41.2%) Conclusions: 18F-FDG PET/CT could significantly influence management of patients with STS, particularly for restaging.

Keyphrases

soft tissue
lymph node
pet ct
primary care
stem cells
lower limb